NCT01681628 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Callahan RJ
Tapping the healer within. New York, NY: McGraw-Hill, 2001
Connolly S, Sakai C
Brief trauma intervention with Rwandan genocide-survivors using thought field therapy. Int J Emerg Ment Health. 2011;13(3):161-72.
Ertl V, Pfeiffer A, Schauer E, Elbert T, Neuner F
Community-implemented trauma therapy for former child soldiers in Northern Uganda: a randomized controlled trial. JAMA. 2011 Aug 3;306(5):503-12. doi: 10.1001/jama.2011.1060.
Feinstein D
Energy psychology in disaster relief. Traumatology 14: 127-129, 2008
Sakai CE, Connolly SM, Oas P
Treatment of PTSD in Rwandan child genocide survivors using thought field therapy. Int J Emerg Ment Health. 2010 Winter;12(1):41-9.

Effectiveness of Thought Field Therapy Provided by Community Workers to a Traumatised Population in Uganda: a Randomised Trial

Clinical trial NCT01681628 - References